[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336999-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-336999-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","overexpression-of-cdca8-predicts-poor-prognosis-and-drug-insensitivity-in-lung-adenocarcinoma","Overexpression of CDCA8 predicts poor prognosis and drug insensitivity in lung adenocarcinoma","","Background: Lung adenocarcinoma (LUAD) is the most prevalent lung cancer, yet reliable biomarkers for diagnosis, therapy, and prognostic evaluation remain limited. Cell division cycle-associated 8 (CDCA8), a cell-cycle regulator with elevated expression across cancers, has an unclear relationship to LUAD outcomes. Methods: CDCA8–prognosis links were assessed using TCGA, followed by enrichment and gene ontology analyses, immune infiltration correlation, immunohistochemistry validation, and drug-sensitivity comparisons across expression levels. Results: CDCA8 was higher in tumors than normal tissue, associated with worse survival, and linked to diagnostic value. Conclusion: CDCA8 upregulation correlates with poor survival and immune infiltration, supporting its use as a LUAD biomarker and a reference for personalized medication.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/overexpression-of-cdca8-predicts-poor-prognosis-and-drug-insensitivity-in-lung-adenocarcinoma/336999/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/overexpression-of-cdca8-predicts-poor-prognosis-and-drug-insensitivity-in-lung-adenocarcinoma/336999.png","ImageObject",300,407,{"name":42,"@type":43},"Eden","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the clinical problem this study addresses in lung adenocarcinoma (LUAD)?","Question",{"text":63,"@type":64},"LUAD lacks specific biomarkers that support diagnosis, treatment selection, and prognostic assessment. The study aims to identify whether CDCA8 can fill this gap.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the study evaluate the relationship between CDCA8 and LUAD prognosis?",{"text":68,"@type":64},"The association was analyzed using the TCGA dataset, with gene enrichment/gene ontology analyses and immune infiltration correlation. Immunohistochemistry was used to assess CDCA8 expression differences between tumors and controls, and survival was evaluated using Kaplan–Meier analysis.",{"name":70,"@type":61,"acceptedAnswer":71},"What drug-related finding links CDCA8 to treatment sensitivity?",{"text":72,"@type":64},"Higher CDCA8 expression was reported to be associated with increased sensitivity to certain anticancer drugs in LUAD, indicating potential value for treatment personalization.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336999,1790141545,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Gu et al. BMC Medical Genomics (2024) 17:265 BMC Medical Genomics  \n[https://doi.org/10.1186/s12920-024-02019-x](https://doi.org/10.1186/s12920-024-02019-x)  \nRESEARCH Open Access  \nOverexpression of CDCA8 predicts poor prognosis and drug insensitivity in lung adenocarcinoma  \nHuiquan Gu 1, Xinzheng Gao2, Wenlong Han 1, Fangyu Wang 1, Hanqiang Zhang3, LongyuYao3, Weimin Chen 1,4* and Qiang Liu 1,4*  \nAbstract  \nBackground Lung adenocarcinoma (LUAD) accounts for the highest proportion of lung cancers; however, specific biomarkers are lacking for diagnosis, treatment, and prognostic assessment. Cell division cycle-associated 8 (CDCA8) is a cell cycle regulator with elevated expression in various cancers. However, the association between CDCA8 expression and LUAD prognosis remains unclear.  \nMethods The association between CDCA8 and LUAD prognosis was evaluated based on the The Cancer  \nGenome Atlas (TCGA) dataset, and CDCA8 related functions were determined using gene enrichment and gene ontology analyses. We also analyzed the association between CDCA8 expression and immune cell infiltration. Immunohistochemistry was used to determine the differential expression of CDCA8 in tumors and controls. Finally, we evaluated the differences in the sensitivity of different levels of CDCA8 to different anticancer drugs in LUAD. Results CDCA8 expression was significantly higher in primary LUAD tumors than in normal tissues (P \u003C 0. 001) . Moreover, Kaplan–Meier survival analysis demonstrated that high CDCA8 expression predicted poor survival inpatients with LUAD (P = 0 . 006) . The receiver operating characteristic (ROC) curves indicated that CDCA8 was an effective guide for the diagnosis of LUAD. Functional annotation indicated that CDCA8 might be involved in functions such as p53 stabilization, nucleotide metabolism, RNA-mediated gene silencing, and the G2/M phase checkpoint. Immune infiltration results suggested that CDCA8 was positively correlated with Th2 cells and Tgd and negatively correlated with Eosinophils and Mast cells (P \u003C 0. 01) . In addition, elevated expression of CDCA8 may increase the sensitivity of patients to certain anticancer drugs.  \nConclusions CDCA8 upregulation is significantly associated with poor survival and immune infiltration in patients with LUAD. Our study suggests that CDCA8 can be used as a biomarker for LUAD prognosis and a reference for personalized medication.  \n†Huiquan Gu and Xinzheng Gao contributed equally to this work.  \n*Correspondence: Weimin Chen [470048098@qq.com](470048098@qq.com)[ ](470048098@qq.com)Qiang Liu [744526211@qq.com](744526211@qq.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nGraphical Abstract  \nKeywords LUAD, CDCA8, Biomarker, Prognosis, Sensitivity  \nIntroduction  \nLung cancer has become one of the most common malignant tumors worldwide in recent years, with a reported rate of approxim","cbCaiclyaMKW3KyJ","https://ap.wps.com/l/cbCaiclyaMKW3KyJ","pdf",8228708,18,"English","# Abstract\n# Introduction\n# Methods\n# Results\n# Conclusions\n# Keywords","[{\"question\":\"What is the clinical problem this study addresses in lung adenocarcinoma (LUAD)?\",\"answer\":\"LUAD lacks specific biomarkers that support diagnosis, treatment selection, and prognostic assessment. The study aims to identify whether CDCA8 can fill this gap.\"},{\"question\":\"How did the study evaluate the relationship between CDCA8 and LUAD prognosis?\",\"answer\":\"The association was analyzed using the TCGA dataset, with gene enrichment/gene ontology analyses and immune infiltration correlation. Immunohistochemistry was used to assess CDCA8 expression differences between tumors and controls, and survival was evaluated using Kaplan–Meier analysis.\"},{\"question\":\"What drug-related finding links CDCA8 to treatment sensitivity?\",\"answer\":\"Higher CDCA8 expression was reported to be associated with increased sensitivity to certain anticancer drugs in LUAD, indicating potential value for treatment personalization.\"}]","Overexpression of CDCA8 predicts poor prognosis and drug insensitivity in lung adenocarcinoma | PDF",1790017351,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1912a4503d161a7dccf7b2e4cc76a276.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d3cd170fe6cb32fbce7c9f4316c92630.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/811538f4aaef6e2cc525e12b5ed30622.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a14475f9cb82c983728f150c4a93b5de.webp",980,1306]